Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative.

Cancer Epidemiol Biomarkers Prev 26 1345-1348 01/01/2017

Abstract

Use of calcium channel blockers (CCBs) has been associated with increased risk of breast cancer in some, but not all, studies. Differences in reported associations from prior studies may be due, in part, to inadequate control of confounding factors.